Welcome to SNMMI
To improve health care by advancing molecular imaging and therapy
- Nuclear Medicine Week
- Annual Meeting Highlights
- Save the Date!
- CME, ACPE & VOICE Credit
The Latest News
In Memory of
Henry N. Wagner, Jr., MD
Government Relations
- May 7, 2013 NRC Issues Enforcement Guidance Memorandum Regarding Rubidium-82
- May 3, 2013 NRC Issues Regulatory Issue Summary Regarding Molybdenum-99
- Apr 19, 2013 Comment Letter Submitted to CMS Regarding Coverage for Amyloid PET Imaging
- Apr 16, 2013 NRG and Mallinckrodt Comment on the Status of the HFR
Molecular Imaging
- May 8, 2013 Patients may expose others to radiation after nuclear imaging
- Dopaminergic dysfunction may not indicate Lewy body dementia
- MILabs introduces small-animal imaging devices
- India plans periodic inspections of all clinical-trial sites
- FDA seeks input on medical device labeling proposal
- N.J. bill would mandate coverage of more breast tests
- CMS to host provider call on EHR incentives
Keep Up-to-Date
- New! 2013 Annual Meeting Discounted Hotel Deadline is May 9
- Application Deadlines Approach for 6 Scholarships & Awards
- SNMMI Launches Online Dose Optimization Resource
- SNMMI Releases Brain Amyloid Imaging Infographic
- Virtual Catalog is Now Available
- JNM and JNMT Full Text iPad/iPhone App Now Available
SNMMI Events & Announcements
JNM
Journal of Nuclear Medicine
Every month, JNM brings readers around the globe clinical investigations, basic science reports, continuing education articles, book reviews, employment opportunities, and updates on rapidly changing issues in practice and research.
JNMT
Journal of Nuclear Medicine Technology
Published quarterly, JNMT focuses on technology, quality assurance, radiation safety, and the clinical applications of nuclear medicine.
Molecular Imaging
Molecular Imaging
The bimonthly journal Molecular Imaging is an authoritative resource for molecular imaging research covering all modalities, with special attention given to emerging techniques, innovative model systems and new imaging agents at the interface between basic science and medicine.















